Literature DB >> 6177323

Antibodies to collagen in scleroderma.

A M Mackel, F DeLustro, F E Harper, E C LeRoy.   

Abstract

Using the enzyme-linked immunosorbent assay (ELISA), we detected antibodies to interstitial (type I) and basement membrane (type IV) collagens in the sera of patients with scleroderma (systemic sclerosis). Antibodies against type IV collagen were found in significant levels in these patients and correlated with the presence of abnormal pulmonary diffusion capacity. Levels of antibodies to type I collagens also correlated significantly with pulmonary diffusion capacity. Absorption of sera with type I or type IV collagens before analysis in the ELISA eliminated reactivity in an antigen-specific pattern, indicating that these antibodies reacted with determinants specific for either type I or type IV collagens. The removal of immune complexes by ultracentrifugation had no effect on serum antibody levels. Autoantibodies to basement membrane and interstitial collagens may participate in the pathogenesis of scleroderma.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6177323     DOI: 10.1002/art.1780250505

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  22 in total

Review 1.  Rheumatology.

Authors:  R A Asherson; R Cervera; D P D'Cruz; G R Hughes
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

2.  Antibodies to mouse laminin in patients with systemic sclerosis (scleroderma) recognize galactosyl (alpha 1-3)-galactose epitopes.

Authors:  A Gabrielli; M Candela; A M Ricciatti; M L Caniglia; J Wieslander
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

3.  Antireticulin antibody in systemic sclerosis.

Authors:  T Mahmud; M Peakman; G Senaldi; A McWhirter; C M Black; D Vergani
Journal:  Ann Rheum Dis       Date:  1990-03       Impact factor: 19.103

4.  Lymphocytotoxic autoantibodies in progressive systemic sclerosis.

Authors:  K Herrmann; J Schaller; U F Haustein; C Baldauf; S Kiessig
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

Review 5.  Pathogenesis of scleroderma: the interrelationship of the immune and vascular hypotheses.

Authors:  E M Sternberg
Journal:  Surv Immunol Res       Date:  1985

6.  Autoantibodies to types I and IV collagen and heart valve disease in systemic lupus erythematosus/antiphospholipid syndrome.

Authors:  José Pardos-Gea; Josefina Cortés-Hernández; Jesus Castro-Marrero; Eva Balada; José Ordi-Ros
Journal:  Clin Rheumatol       Date:  2017-03-10       Impact factor: 2.980

7.  Expression of types I, III and IV collagen genes in fibrotic skin and nerve lesions of toxic oil syndrome patients.

Authors:  J J Gomez-Reino; M Sandberg; P E Carreira; E Vuorio
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

8.  Systemic sclerosis: a collagen or microvascular disease?

Authors:  M I Jayson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-23

9.  Immunohistologic and ultrastructural study of the sclerotic skin in chronic graft-versus-host disease in man.

Authors:  A Janin-Mercier; A Devergie; D Van Cauwenberge; J H Saurat; M Bourges; C M Lapiere; E Gluckman
Journal:  Am J Pathol       Date:  1984-05       Impact factor: 4.307

10.  Autoantibodies in childhood scleroderma.

Authors:  R M Bernstein; R S Pereira; A J Holden; C M Black; A Howard; B M Ansell
Journal:  Ann Rheum Dis       Date:  1985-08       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.